Medicare Enrolled

Dr. George Younis, MD

Cardiovascular Disease · Houston, TX
Practice pattern: Cardiac & Electrophysiology— Practice combining cardiac and electrophysiology services
Low-engagement
6560 FANNIN ST STE 1750, Houston, TX 77030
7137900400
In practice since 2006 (19 years)
NPI: 1760449268 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Younis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Younis? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Younis

Dr. George Younis is a cardiovascular disease in Houston, TX, with 19 years in practice. Based on federal Medicare data, Dr. Younis performed 8,234 Medicare services across 4,721 unique beneficiaries.

Between the years covered by Open Payments, Dr. Younis received a total of $11,055 from 56 pharmaceutical and/or device companies across 458 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Younis is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 5% volume in TX$ $11,055 industry payments

Medicare Practice Summary

Medicare Utilization ↗
8,234
Medicare services
Top 5% in TX for cardiovascular disease
4,721
Unique beneficiaries
$159
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~433 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)1,704$89$190
Electrocardiogram (EKG), 12-lead1,365$10$66
Regadenoson injection (Lexiscan) for heart stress test1,345$43$150
Contrast dye for imaging (iodine-based)1,305$0$4
Echocardiogram, transthoracic435$144$800
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician354$55$535
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries335$637$856
Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan330$1,932$7,500
Nuclear medicine study of heart muscle blood flow by pet324$146$500
New patient office visit (45-59 min)194$118$275
Hospital follow-up visit, moderate complexity72$61$176
Electrocardiogram (ecg) 2-day continuous with review and report by health care professional63$52$275
Ultrasound study of arm or leg veins with compression and maneuvers52$146$579
Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional51$670$1,500
Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional50$21$80
Office visit, established patient (20-29 min)50$62$110
Ultrasound of both sides of head and neck blood flow34$145$582
Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes29$9$79
Initial hospital admission, moderate complexity28$98$200
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes23$41$216
Insertion of tube in coronary artery for diagnosis with review by radiologist21$374$7,405
Ultrasonic guidance for blood vessel access15$21$250
Technetium tc-99m tetrofosmin, diagnostic, per study dose15$132$1,867
Nuclear medicine studies of heart muscle at rest and with stress and spect14$293$2,000
Ultrasound study of arm and leg arteries13$53$750
Ultrasound of leg arteries or artery grafts13$182$1,000
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.3% high complexity
46.0% medium
48.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$11,055
Total received (2018-2024)
Avg $1,579/year across 7 years
Top 29% in TX for cardiovascular disease
56
Companies
458
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,799 (97.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$256 (2.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,427
2023
$888
2022
$1,021
2021
$1,395
2020
$1,762
2019
$1,955
2018
$2,608

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$854
Amgen Inc.
$767
Janssen Pharmaceuticals, Inc
$708
PFIZER INC.
$626
Amarin Pharma Inc.
$617
E.R. Squibb & Sons, L.L.C.
$599
Gilead Sciences, Inc.
$546
SANOFI-AVENTIS U.S. LLC
$508
Boston Scientific Corporation
$439
Novartis Pharmaceuticals Corporation
$419
Abbott Laboratories
$359
Astellas Pharma US Inc
$342
AstraZeneca Pharmaceuticals LP
$337
Medtronic, Inc.
$311
Medicure Pharma Inc.
$287
Impulse Dynamics (USA) Inc.
$238
Hitachi Healthcare Americas Corp.
$226
Boehringer Ingelheim Pharmaceuticals, Inc.
$190
Bardy Diagnostics, Inc.
$165
ABIOMED
$160
Chiesi USA, Inc.
$151
BIOTRONIK INC.
$140
Novo Nordisk Inc
$133
Penumbra, Inc.
$130
BOSTON SCIENTIFIC CORPORATION
$129
Regeneron Healthcare Solutions, Inc.
$125
CARDIVA MEDICAL, INC.
$124
ARBOR PHARMACEUTICALS, INC.
$111
Edwards Lifesciences Corporation
$108
Cardiovascular Systems Inc.
$95
Inari Medical, Inc.
$90
Philips Electronics North America Corporation
$88
ShockWave Medical, Inc
$82
CHIESI USA, INC.
$74
Allergan Inc.
$67
Esperion Therapeutics, Inc.
$63
Kowa Pharmaceuticals America, Inc.
$56
Arbor Pharmaceuticals, Inc.
$52
SCPHARMACEUTICALS INC.
$50
Lexicon Pharmaceuticals, Inc.
$49
Merck Sharp & Dohme Corporation
$46
HeartFlow, Inc.
$44
Merck Sharp & Dohme LLC
$39
Baxter Healthcare
$36
Bayer Healthcare Pharmaceuticals Inc.
$34
Lundbeck LLC
$31
Medtronic Vascular, Inc.
$31
Actelion Pharmaceuticals US, Inc.
$28
PORTOLA PHARMACEUTICALS, LLC
$21
Kiniksa Pharmaceuticals, Ltd.
$21
Shockwave Medical, Inc
$21
Preventice Services, LLC
$20
AngioDynamics, Inc.
$19
Alnylam Pharmaceuticals Inc.
$17
Avinger Inc.
$15
iRhythm Technologies, Inc.
$14
Top 3 companies account for 21.1% of total payments
Associated products mentioned in payments ›
AMPLATZER TALISMAN · ANDEXXA · Advisa · Arcalyst · BRILINTA · BYSTOLIC · CAMZYOS · CHANTIX · CLEVIPREX · CLEVIPREX 50MG/100ML · COBALT DR MRI SURESCAN · COREVALVE EVOLUT R · Carnation Ambulatory Monitor · Connectivity and Remote care · Corlanor · Diamondback Coronary · Diamondback Peripheral · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · EVENITY · Edarbi · Edarbyclor · FARXIGA · FFRct · FLOWTRIEVER CATHETER · FUROSCIX · GENERAL THERAPIES · GENERAL - VASCULAR ACCESS · HMG-CoA reductase inhibitor. · Hillrom - Carnation Ambulatory Monitor · Impella · Indigo System · JARDIANCE · KENGREAL · KENGREAL 50MG/10ML L · Kerendia · LEQVIO · LEXISCAN · LifeVest · Livalo · MICRA · MULTAQ · Micra · NEXLETOL · NORTHERA · ONPATTRO · OPSUMIT MACITENTAN · OPTIMIZER · Optimizer · Optimizer Smart System · Ozempic · PANTHERIS · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · ROTAPRO · Ranger · Repatha · S · SAPIEN 3 Ultra RESILIA · SAVVYWIRE · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · Turbo-Power · VENASEAL · VERQUVO · VYNDAQEL · Vascepa · WATCHMAN · Wegovy · XARELTO · XIENCE SKYPOINT · Xience Sierra Coronary Stent · ZIO Patch · ZYPITAMAG
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $134 per 100 Medicare services performed
Looking for a cardiovascular disease in Houston?
Compare cardiovascular diseases in the Houston area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
385
Per 100K population
8.1
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Younis is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 5% in TX), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Younis experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Younis performed 1,704 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Younis receive payments from pharmaceutical companies?
Yes. Dr. Younis received a total of $11,055 from 56 companies across 458 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Younis's costs compare to other cardiovascular diseases in Houston?
Dr. Younis's average Medicare payment per service is $159. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Younis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →